ACM
RXST icon

ADAR1 Capital Management’s RxSight RXST Stock Holding History

ADAR1 Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Buy
50,000
+6,750
+16% +$40.7K 0.01% 246
2026
Q1 		$266K Buy
43,250
+21,447
+98% +$178K 0.02% 247
2025
Q4 		$227K Buy
+21,803
New +$219K 0.02% 228

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ADAR1 Capital Management's RXST Position: Q2 2026 in Review

ADAR1 Capital Management increased its RxSight (RXST) stake by 16% in Q2 2026, buying an estimated $40.7K and bringing the position to 50,000 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #246.

ADAR1 Capital Management first reported a position in RXST in Q4 2025 and has held it in 3 quarters since. The position peaked at $266K in Q1 2026. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • ADAR1 Capital Management held 50,000 shares of RxSight worth $241K as of Q2 2026.
  • ADAR1 Capital Management bought 6,750 RxSight shares in Q2 2026, an estimated $40.7K.
  • RxSight made up 0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #246 holding.
  • ADAR1 Capital Management first reported a position in RxSight in Q4 2025 and has held it in 3 quarters since.
  • ADAR1 Capital Management's RxSight position peaked at $266K in Q1 2026.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.